STRENSIQ
Google image searchProduct monograph
Active ingredient
asfotase alfa, 40 MG/ML
DIN: 02444615
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: 18MG/0.45 ML SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: ALEXION PHARMA GMBH
Date: 20-OCT-2015
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AB — Enzymes (ATC, ATC/DDD)
- A16AB13 — ASFOTASE ALFA (ATC/DDD)
Reference brand drug: Strensiq
